IL138216A0 - Novel fdrg protein and nucleic acid molecules and uses therefor - Google Patents

Novel fdrg protein and nucleic acid molecules and uses therefor

Info

Publication number
IL138216A0
IL138216A0 IL13821699A IL13821699A IL138216A0 IL 138216 A0 IL138216 A0 IL 138216A0 IL 13821699 A IL13821699 A IL 13821699A IL 13821699 A IL13821699 A IL 13821699A IL 138216 A0 IL138216 A0 IL 138216A0
Authority
IL
Israel
Prior art keywords
fdrg
protein
novel
nucleic acid
acid molecules
Prior art date
Application number
IL13821699A
Other languages
English (en)
Original Assignee
Millennium Pharm Inc
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc, Dana Farber Cancer Inst Inc filed Critical Millennium Pharm Inc
Publication of IL138216A0 publication Critical patent/IL138216A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL13821699A 1998-03-02 1999-03-02 Novel fdrg protein and nucleic acid molecules and uses therefor IL138216A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3353998A 1998-03-02 1998-03-02
PCT/US1999/004548 WO1999045135A1 (fr) 1998-03-02 1999-03-02 Nouvelles molecules fdrg de proteines et d'acide nucleique et utilisation desdites molecules

Publications (1)

Publication Number Publication Date
IL138216A0 true IL138216A0 (en) 2001-10-31

Family

ID=21870993

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13821699A IL138216A0 (en) 1998-03-02 1999-03-02 Novel fdrg protein and nucleic acid molecules and uses therefor

Country Status (6)

Country Link
EP (1) EP1058737A4 (fr)
JP (1) JP2002516067A (fr)
AU (1) AU3065799A (fr)
CA (1) CA2322425A1 (fr)
IL (1) IL138216A0 (fr)
WO (1) WO1999045135A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE364628T1 (de) * 1999-03-08 2007-07-15 Genentech Inc Verfahren und zusammensetzungen zur diagnose von tumoren
AU2001249929A1 (en) * 2000-04-07 2001-10-23 Dana-Farber Cancer Institute Inc. Fdrg proteins and nucleic acid molecules and uses therefor
AU2001254967B2 (en) * 2000-05-13 2005-06-23 Bioacta Ltd Anti-angiogenic polypeptides
US6869766B2 (en) 2000-12-22 2005-03-22 The Regents Of The University Of California Gene associated with regulation of adiposity and insulin response
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2005068663A2 (fr) * 2004-01-14 2005-07-28 Janssen Pharmaceutica Nv Procedes d'utilisation de genes cible de recepteur alpha active par proliferateur de peroxisome
EP1586902A3 (fr) * 2004-03-30 2006-02-15 F.Hoffmann-La Roche Ag ANGPTL4/FIAF comme marqueur pour la modulation de PPARdelta
RU2380411C2 (ru) 2004-07-20 2010-01-27 Дженентек, Инк. Способ ингибирования пролиферации гепатоцитов, способ ингибирования клеточной адгезии гепатоцитов и способ ингибирования биологической активности angptl4 в гепатоцитах или предшественниках гепатоцитов
US8604185B2 (en) 2004-07-20 2013-12-10 Genentech, Inc. Inhibitors of angiopoietin-like 4 protein, combinations, and their use
JP4947717B2 (ja) 2004-07-20 2012-06-06 ジェネンテック， インコーポレイテッド アンジオポエチン様４タンパク質のインヒビター、組み合わせ、およびそれらの使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814464A (en) * 1994-10-07 1998-09-29 Regeneron Pharma Nucleic acids encoding TIE-2 ligand-2
US6030831A (en) * 1997-09-19 2000-02-29 Genetech, Inc. Tie ligand homologues
WO1999032515A2 (fr) * 1997-12-19 1999-07-01 Zymogenetics, Inc. Homologue de l'angiopoietine, adn le codant et procede de production dudit homologue

Also Published As

Publication number Publication date
JP2002516067A (ja) 2002-06-04
EP1058737A4 (fr) 2003-01-02
CA2322425A1 (fr) 1999-09-10
EP1058737A1 (fr) 2000-12-13
AU3065799A (en) 1999-09-20
WO1999045135A1 (fr) 1999-09-10

Similar Documents

Publication Publication Date Title
AU4567499A (en) Novel mtbx protein and nucleic acid molecules and uses therefor
IL135823A0 (en) Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor
AU3510200A (en) Human dickkopf-related protein and nucleic acid molecules and uses therefor
EP1112354A4 (fr) Nouvelles molecules de proteine kinase et leurs utilisations
EP1001964A4 (fr) Molecules d'acide nucleique tango-78, tango-79 et tango-81
AU3354499A (en) Human mekk proteins, corresponding nucleic acid molecules, and uses therefor
AU1934899A (en) Toxoplasma gondii proteins, corresponding nucleic acid molecules, and uses thereof
ZA9710163B (en) Novel carboxylesterase nucleic acid molecules, proteins and uses thereof.
IL138216A0 (en) Novel fdrg protein and nucleic acid molecules and uses therefor
EP1051427A4 (fr) Molecules d'acide nucleique et proteine spoil, et utilisations
EP1186615A4 (fr) Proteine et adn de cette proteine
AU5901199A (en) Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
EP1071749A4 (fr) Molecules d'acide nucleique et de proteine lrsg et leurs utilisations
EP1425289A4 (fr) Nouvelles molecules d'acide nucleique et polypeptidiques
AU3977699A (en) Ags proteins and nucleic acid molecules and uses therefor
EP1109824A4 (fr) Proteines bag et molecules d'acide nucleique les codant
AU2001249929A1 (en) Fdrg proteins and nucleic acid molecules and uses therefor
ZA9811354B (en) Novel flea epoxide hydrolase nucleic acid molecules proteins and uses thereof
IL120704A0 (en) Flea protease proteins nucleic acid molecules and uses thereof
AU5312699A (en) Novel mp-7 protein and nucleic acid molecules and uses therefor
AU4826899A (en) Novel msp-5 protein and nucleic acid molecules and uses therefor
EP1066310A4 (fr) Proteines et molecules d'acides nucleiques de neokine et leur utilisation
EP1007682A4 (fr) Nouvelles molecules d'acide nucleique et leurs utilisations
AU2002323612A1 (en) Novel clark protein and nucleic acid molecules and uses therefor
EP1012160A4 (fr) Molecules d'acides nucleiques et polypeptides tango-72 et tango-77